Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00078949

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations
  • Rush-Presbyterian-St. Luke's Medical Centre Chicago, Illinois, United States
  • Indiana University Medical Center Indianapolis, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Cincinnati, Barrett Cancer Centre Cincinnati, Ohio, United States
View all 27 locations
View Trial Details
Completed

Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

NCT00039130

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • Naval Medical Center - San Diego San Diego, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 31 locations
View Trial Details
Completed

A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111)

NCT03314922

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Aichi Cancer Center Hospital Aichi, Japan
  • National Hospital Organization Kyushu Cancer Center Fukuoka, Japan
  • Cancer Institute Hospital of Jfcr Kōtoku, Japan
  • Nagoya City University Hospital Nagoya, Japan
View Trial Details
Completed

Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma

NCT00377052

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • QEII Health Sciences Center Halifax, Nova Scotia, Canada
View Trial Details
Completed

Bortezomib in Treating Patients With Mantle Cell Lymphoma

NCT00030875

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • British Columbia Cancer Agency Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
View Trial Details
Completed

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT01399372

Conditions
Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Arizona Oncology-Deer Valley Center Phoenix, Arizona, United States
View all 45 locations
View Trial Details

Related conditions